- Leerink Swann Upgrades Illumina; Revises Estimates for Life Tech, Thermo Fisher, Others
July 23, 2012 / GenomeWeb Daily News
- Goldman Sachs Revises Estimates for Life Science Tools Firms
April 13, 2012 / GenomeWeb Daily News
- Goldman Sachs Upgrades Cepheid and Myriad, Restarts Thermo Fisher Coverage
September 23, 2011 / GenomeWeb Daily News
- Goldman Sachs Lowers Estimates on Illumina, But Favors MiSeq Growth Over PGM
June 24, 2011 / GenomeWeb Daily News
- Goldman Sachs Issues Buy Rating for Hologic, Noting Contributions from Gen-Probe Purchase
August 7, 2012 / GenomeWeb Daily News